Roche is committed to Switzerland and our Basel/Kaiseraugst site in the long term. Our roots in this region are strong, and we are determined to deepen them further. To meet the challenges of the future and remain at the forefront, we are continuously developing. Our strategic site development is flexible and responsive, adapted to the dynamic local and global business developments of Roche and our environment. This is how we not only ensure our competitiveness, but also create the basis for sustainable corporate success.
Roche will invest CHF 1.2 billion in another research and development building, the renewal of the synthetic chemical molecule production and a building for the Institute of Human Biology. The new buildings will expand the infrastructure for future innovations along the entire pharmaceutical value chain, from research to production.
Sustainability is at the heart of everything we do. Whether we are developing new buildings or contributing to innovative research, production and working environments, we prioritise high-quality, durable materials, reduce energy consumption, employ regenerative energy and create living spaces that promote biodiversity. This is how we take responsibility and create sustainable value – for today and for future generations.